The actions of morphine at the cellular level were first investigated in the neocortex (KrnjeviC, 1965) , but in the intervening years there has been "no systematic study of the effects of ligands, having high specificity for different opiate receptors, on neurones of the cerebral cortex" (Duggan and Fleetwood-Walker, 1992) . There are three types of reasons why an increased understanding of opiate actions in the anterior cingulate cortex is desirable. First, morphine and its congeners produce mood alterations such as a feeling of tranquility. The cellular substrates for these effects are not understood but there is electroencephalographic evidence for direct cortical involvement (reviewed Duggan and North, 1984; Duggan and Fleetwood-Walker, 1992) . Second, opioid drugs selective for w-receptors are strongly reinforcing, and this probably involves the dopamine projections from the midbrain to the nucleus accumbens and cingulate cortex (DiChiara and Koob, 1992) . Third, three types of opioid receptor, as well as endogenous opioid peptides, are present in the cerebral cortex (reviewed Mansour and Watson, 1992) . Although there are regional and species differences, &re-ceptors and [Leus]enkephalin immunoreactivity are diffusely distributed in layers II, III, V, and VI, whereas h-receptors are most prominent in layers I and III/IV (McGinty et al., 1984; Mansour et al., 1987 Mansour et al., , 1988 Blackburn et al., 1988; Mansour and Watson, 1992) . The physiological role of the endogenous opioids remains obscure.
In several other parts of the nervous system, opiates acting at p-and b-receptors have two main direct cellular actions that are readily detectable electrically . First, they inhibit action potential firing by increasing the membrane potassium conductance. Where synaptic connections among cells are intact, such inhibition of interneurons can lead to excitation of other cells; this is seen in hippocampal pyramidal cells (Zieglggnsberger et al., 1979; Madison and Nicoll, 1988) and dopamine-containing neurons of the ventral tegmental area (Johnson and North, 1992) . Second, opioids reduce voltage-dependent calcium currents (reviewed by . In many parts of the CNS and PNS opioids reduce the release of neurotransmitters (Illes, 1989) but, in most cases, it remains unclear whether inhibition of transmitter release is causally related to the effects on potassium and calcium channels (e.g., Cohen et al., 1992) .
The aim of the present work was to determine the actions of opioids selective for p-and K-receptors on neurons of the rat anterior cingulate cortex. Intracellular recording was used so that the neurons could be labeled for subsequent histology. Synaptic potentials mediated by excitatory amino acids and GABA were isolated pharmacologically; their amplitudes were used, with appropriate controls, as indices of the effects of opioids on transmitter release.
Materials and Methods
The methods have been described previously (Tanaka and North, 1993 vibratome (350 pm). The tissue slice was submerged in a flowing physiological saline that contained (mM) NaCl, 126; KCl, 2.5; CaCl,, 2.4; MgC&, 1.2; NaH2P0,, 1.2; NaHCO,, 26; dextrose, 10 (saturated with 95% 02, 5% CO>; preheated to 36°C). Intracellular recordings were made from neurons within layer V, using electrodes that contained potassium methylsulfate (2 M) and biocytin (20 mg/ml in 10 mM Tris buffer at pH 7.2). Tissues were fixed after the recordings in Zamboni fixative, incubated with extravidin-peroxidase conjugate, and reacted with diaminobenzidine (5 m&ml in 0.01% hydrogen peroxide). Focal electrical stimulation was applied using two tungsten-in-glass electrodes; these were placed on the surface of the subcortical white matter or within layer V. The components of the synaptic potentials mediated by excitatory amino acids (hereafter referred to as glutamate) and mediated by GABA were isolated with receptor antagonists (see Tanaka and North, 1993) . Bicuculline (500 nM) was used to isolate the glutamate component and (k)-2-amino-5-phosphonovaleric acid (APV; 50 FM) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 WM) were added to isolate the GABA component. Drugs were applied by changing the superfusing solution.
, naloxone, L-glutamate, and muscimol. Glutamate and [Met5]enkephalin were also applied by pressure ejection; a few nanoliters of a solution containing 500 mM glutamate or 10 mM [Mets]enkephalin were ejected by a pulse of pressure from a glass micropipette, the tip of which (2-5 pm) was positioned beneath the surface of the superfusing solution and above the tissue slice. The reductions of amplitude of the synaptic potentials by different concentrations of opioid agonists are expressed as percentages (mean ? standard deviation). Equilibrium dissociation constants for naltrindole (I&,, nM) were estimated for individual neurons from KD = 3/(DR -l), where DR is the ratio by which the agonist concentration had to be increased to obtain the same percentage inhibition in the presence of 3 nM naltrindole. This assumes that naltrindole acted as a competitive antagonist (Portoghese et al., 1988) ; in a few cells to which several concentrations of naltrindole were applied they produced increasing rightward shifts in the concentration-response curve for [Mets] enkephalin (see Figs. 3, 6) .
Results
The 52 neurons included in this study had resting membrane potentials of -66 * 6.5 mV (mean & SD) and input resistances [measured from the amplitude of small (< 10 mV) hyperpolarizing electrotonic potentials] of 58 k 23 MQ. Histological examination allowed the cells to be classed as pyramidal or nonpyramidal (see Tanaka and North, 1993) was equally effective at depressing the EPSP generated from either site when this was compared in the same cell. The minimal effective concentration of [Met5]enkephalin was 30 nM, and the EPSP was inhibited by 60 * 1.6% (n = 7) with a concentration of 30 PM (Fig. 1) . The effect of [Mets]enkephalin on the EPSP was not different in neurons that were hyperpolarized (see below) and those that were not. The reduction of the EPSP by [Mets] enkephalin was mimicked by DPDPE (Fig. 2) and by [D-Ala2]deltorphin-II, which are agonists selective for &receptors. DPDPE (100 nM, 3 min) reduced the EPSP amplitude by 39 -t 9.4% (n = 8) of control, and [D-Ala2]deltorphin-II (100 nM, 3 min) reduced the EPSP amplitude by 33 ? 1.0% (n = 3). The effect was reversibly blocked by naloxone (1 HM, 10 min) (Fig. 1A) and by naltrindole (l-l 0 nM) (Fig. 3) which is an antagonist selective for fi-receptors. Naloxone
(1 KM, 10 min) reduced the inhibition of the EPSP by [Met5]enkephalin (10 ELM) from 40 * 5.3% (n = 6) to 13 f 1.8% (n = 6) (Fig. 1) . Naltrindole (10 nM) reduced the Wash was reduced to 39 f 5.2% of control by DPDPE (100 nM); after adding APV (50 PM), the remaining non-NMDA component was reduced to 44 + 3.7% of control. After washing out the APV, CNQX (10 PM) was added; DPDPE reduced the NMDA component to 36% f 1.2% of control. Glutamate was applied by pressure ejection and it evoked a depolarization of lo-30 mV.
[Mets]enkephalin (10 PM) did not affect the response to glutamate (n = 6) (Fig. 2) . The same results were obtained with (n = 5) or without (n = 3) bicuculline (500 nM), and with (n = 4) or without (n = 3) TTX (1 KM).
Inhibition of the synaptic potential mediated by GABA APV and 10 PM CNQX) (Fig. 4) . The effect developed within l-2 min of [Met5]enkephalin reaching the recording chamber and fully recovered when the tissue was washed with control solution for 5-15 min. The inhibition of the IPSP continued unchanged during applications of up to 10 min. The lowest concentration tested (30 nM) inhibited the IPSP by 23 + 8.7% (n = 5); the concentration giving half-maximal inhibition was about 60 nM (Fig. 4) .
The reduction of the fast IPSP by [Met5]enkephalin was mimicked by DPDPE (Fig. 5) , DADLE, and [o-Ala2]deltorphin-II. It was reversibly blocked by naloxone (1 PM) (Fig. 4) and naltrindole (10 nrq 20 min) (Fig. 6) . DPDPE (100 nM, 2 min) reduced the fast IPSP amplitude by 43 f 5.8% (n = 5) ofcontrol, DADLE (100 nM, 2 min) reduced it by 38 + 13.3% (n = 5), and [D-Ala2]deltorphin II (100 nM) reduced it by 73 + 1 .O% (n = 4). Naloxone (1 PM, 10 min) reduced the inhibition of the fast IPSP amplitude by [Met5]enkephalin (10 FM) from 48 & 7.9% (n = 7) to 14 f 5.8% (n = 7). Naltrindole (10 nM, 20 min) reduced the inhibition of the fast IPSP amplitude by [Met5]enkephalin (10 PM) from 5 1 f 7.9% (n = 6) to 27 -t 2.9% and APV (50 PM) were present. Synaptic potentials were evoked by stimulation within layer V. was seen with DAMGO (300 nM) (Fig. 4) or U50488 (1 KM) (n = 5 in each case), and CTOP (300 t-r@ did not affect the inhibition observed with [Mets]enkephalin (10 PM). Muscimol was applied by brief superfusion (5 PM, 10 set) and it evoked a hyperpolarization of 5-10 mV (membrane potential held at -55 mV).
[Met5]enkephalin (10 PM) did not affect the response to muscimol (n = 5) (Fig. 5) . The same results were obtained with (n = 3) or without (n = 2) APV (50 KM) and CNQX (10 PM), and with (n = 3) or without (n = 2) TTX (1 PM). polarization was associated with a decrease in cell input resistance. The amplitude of the hyperpolarizing response became larger when the neuron was held at a depolarized level, and smaller when applied to a hyperpolarized cell. With extracellular potassium concentration ([K+],,) of2.5 mM, the [Mets]enkephalinmediated hyperpolarization reversed in polarity at -103 + 5.5 mV (n = 4). When [K+], was 5 mM and 10 mM these values were -85 + 1.7 mV (n = 4) and -66 + 3.1 mV (n = 4) respectively (Fig. 8) . This corresponds to a change of 6 1 mV for a lo-fold change in [K+], (Fig. 8) . DPDPE (100 nM to 3 WM) hyperpolarized all pyramidal neurons that were hyperpolarized by [Mets]enkephalin (n = 5) (Fig. 7) and this was also concentration dependent. DAMGO (up to 3 FM) had no effect on the membrane potential of pyramidal neurons. Naloxone (1 FM) and naltrindole (10 nM) reversibly blocked the membrane hyperpolarization by [Mets]enkephalin (10 PM) (Fig. 7) .
[Met*]enkephalin (l-10 KM) hyperpolarized five ofseven nonpyramidal neurons (sparsely spiny cell) tested and had no effect on two nonpyramidal neurons. The hyperpolarization persisted in TTX (1 KM) and was associated with a decrease in cell input resistance. DAMGO (100 nM to 3 WM) also caused a concentration-dependent hyperpolarization of all five nonpyramidal neurons, but DPDPE (up to 3 PM) had no effect (n = 5). CTOP (300 nM) reversibly blocked the membrane hyperpolarization by [Met5]enkephalin (10 PM) (Fig. 9) .
Discussion
Presynaptic inhibition qf the EPSP and the IPSP Both NMDA and non-NMDA components of the EPSP, as well as the GABA, receptor-mediated IPSP, were inhibited by row, 140 kF'a for 30 msec applied to pipette containing 10 mM) was applied in different concentrations of extracellular potassium (left to right) and at dif- Considerable evidence supports the conclusion that the opioid receptor type involved in this presynaptic inhibition is a &re-ceptor. This includes the mimicry of the action of [Mets] enkephalin by DPDPE and [D-AlaZ]deltorphin-II, and the lack of effect of DAMGO and U50488. In similar experiments on mammalian neurons in vitro, DPDPE and DAMGO show virtually complete selectivity for 6-and p-receptor subtypes at these concentrations (North et al., 1987) . The evidence also includes the block of the effect by naltrindole at low nanomolar concentrations. Considerable errors are associated with the estimates of the dissociation equilibrium constant (Ku) for naltrindole because complete observations with many antagonist concentrations could rarely be made in a single cell (e.g., Figs. 5, 6) and we therefore used an estimate based upon a single naltrindole concentration and the assumption of competitive antagonism. The estimates are close to those reported by others for d-receptors (Portoghese et al., 1988) and there was no difference between these estimates of the K, values for the inhibition of the EPSP and the IPSP.
Presynaptic inhibition of the release of excitatory amino acids (Jiang and North, 1992; Yuan et al., 1992) ; in that case k-selective agonists are also effective, raising the possibility that the same presynaptic fibers have both types of receptor. Inhibition of release of excitatory amino acids by activation of FL-receptors is also seen in the dorsal horn of the rat spinal cord (Hori et al., 1992) and rat dentate granule cells (Xie et al., 1992) and by K-reCeptOrS in the rat locus ceruleus (McFadzean et al., 1987) and guinea pig dentate gyrus (Wagner et al., 1992) . The rat anterior cingulate cortex is unusual in that the presynaptic inhibition of glutamate release is exclusively through Lreceptors. The origin of the glutamate-containing fibers is not known. Some of them may arise from other pyramidal cells, which would be consistent with our observation that about half of the pyramidal cells express &receptors, as detected by the somatic hyperpolarization.
Presynaptic inhibition of the release of GABA also resulted from b-receptor activation, as previously reported for the rat striatum (Jiang and North, 1992) lateral amygdala (Sugita and North, 1993) and dentate gyrus (Piguet and North, 1993) . The anterior cingulate cortex again differs from those sites in that only d-selective agonists were effective, not both 6-and FL-agonists. The origin of the inhibitory GABA-releasing fibers is not known for certain; however, the stimulating electrodes were placed within layer V, so it is reasonable to assume that local interneurons were being excited. Such local interneurons may be a different population from those directly hyperpolarized by opioids, because the hyperpolarization of nonpyramidal cells was apparently mediated by a h-receptor rather than a &receptor (see below). However, it is also possible that a group of interneurons express p-receptors on their somata, through which hyperpolarization occurs, and d-receptors on their terminals through which inhibition of transmitter release is mediated. There was a difference of about lo-fold between the concentrations of [Mets] enkephalin that inhibited the EPSP and those that inhibited the IPSP. One possibility is that [Met5]enkephalin is more susceptible to degradation as it diffuses to the excitatory terminals as compared to inhibitory terminals; this would imply a very discrete localization of degradative enzymes. A second possibility is that the mechanism by which release is inhibited may be different. For example, the IPSP may be reduced not only because of an action near the terminals but also because hyperpolarization of the cell bodies within the slice reduces their excitability. Third, the receptor reserve may differ for the two sets of neurons. Fourth, the result may indicate distinct subtypes of d-receptor on the glutamate-and GABA-releasing nerve terminals. If this is so, then they do not differ markedly in their affinity for naltrindole; there was no difference between our estimates of the KD for the receptors involved in EPSP and IPSP inhibition. There is evidence for the existence of b-receptor subtypes (Sofuoglu et al., 199 1) ; the isolation of a d-receptor cDNA clone (Evans et al., 1992; Kieffer et al., 1992) will now allow the subtypes to be definitively identified, and the distribution of their RNAs to be determined at the cellular level in the cortex and other tissues.
The direct action of [Met5]enkephalin on about one-half of pyramidal cells was a hyperpolarization that resulted from activation of &receptors. As in other neurons (guinea pig submucous plexus, Mihara and North, 1986 ; rat dentate granule cells, Piguet and North, 1993) , this resulted from an increase in membrane potassium conductance. The finding is consistent with the presence &opioid binding sites in layer V of the rat anterior cingulate cortex (Mansour et al., 1987 (Mansour et al., , 1988 Blackbum et al., 1988) ; presumably a subset of layer V pyramidal cells will contain d-receptor mRNA. A striking finding ofthe present work was that nonpyramidal cells, histologically identified, were also
